News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Fabrinet reported blowout revenue as AI optics demand surged, prompting mid‑term valuation catch‑up long ideas.
  • Accenture is positioned to monetize generative AI (Anthropic) rollouts, fueling mid‑term services re‑rating trade plans.
  • Nano Labs attracts both deep‑value long and high‑risk short calls after pivoting toward AI while facing crypto losses and a large write‑down.
  • McDonald's pullback near its 52‑week low is pitched as a long based on strong free cash flow and a steady dividend.
  • Amerigo Resources has shed its deep‑value label but still offers yield and copper upside as a position for income and cash flow optionality.
  • BlackBerry upgraded to a tactical buy ahead of Q2, with QNX momentum and improving cash flow seen as potential catalysts for a rebound.
  • Journey Medical’s Emrosi approval positions the stock for re‑rating, contingent on reimbursement execution and ongoing legal and short‑interest risks.

Latest Articles

Enlivex Announces $400,000,000 Private Placement

Enlivex Announces $400,000,000 Private Placement

Enlivex Ltd. (Nasdaq: ENLV) has entered into a private placement agreement with a single institutional investor to raise approximately $400 million through the sale of ordinary shares at a premium to the current trading price. The investor has elected to fund using RAIN tokens, linked to decentralized prediction markets in which Enlivex also invest…

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

Standard BioTools announced the sale of its Mass Cytometry business to Multiplex Bio, a $30 million buyout of contingent payments related to Illumina's acquisition of its SomaLogic business, and early FTC approval advancing its merger with Treeline Biosciences. The Mass Cytometry sale ensures product continuity and ongoing investment while enabling…

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce

Pacira BioSciences released a national survey revealing significant impacts of orthopedic pain, especially knee pain, on physically active US workers. The survey underscores the high prevalence of pain affecting income, career opportunities, and quality of life, with a strong interest in long-lasting, non-opioid pain treatments. The findings emphas…

Franklin Electric Reports Second Quarter 2026 Results

Franklin Electric Reports Second Quarter 2026 Results

Franklin Electric reported second quarter 2026 net sales of $622.9 million, up 6% year-over-year, driven by gains across Water Systems, Energy Systems, and Distribution segments. Adjusted diluted EPS rose 18% to $1.55. The company raised its full year 2026 revenue and EPS guidance, citing organic growth initiatives, acquisitions, and solid demand i…

Kratos Completes Construction of $50 Million State-of-the-Art Hypersonic Systems Payload Integration Facility in Indiana Ahead of Schedule

Kratos Completes Construction of $50 Million State-of-the-Art Hypersonic Systems Payload Integration Facility in Indiana Ahead of Schedule

Kratos Defense & Security Solutions has completed construction of its $50 million Indiana Payload Integration Facility (IPIF) ahead of schedule. The 68,000-square-foot facility is designed for advanced manufacturing, integration, and testing of experimental hypersonic payloads to accelerate hypersonic technology development and flight testing. This…

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter, and Declaration of Common Stock Distributions for the Months Ending October, November, and December 2026

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter, and Declaration of Common Stock Distributions for the Months Ending October, November, and December 2026

Oxford Lane Capital Corp. announced its first fiscal quarter 2026 financial results, including a net asset value per share increase to $10.74 and declared monthly common stock distributions of $0.20 per share for October through December 2026. The company reported net investment income of $50.2 million and core net investment income of $93.4 millio…

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Corbus Pharmaceuticals announced FDA clearance to initiate its Phase 3 TEMPO-1 study testing CRB-701, a next-generation antibody drug conjugate targeting Nectin-4, in patients with second-line oropharyngeal squamous cell carcinoma (OPSCC). The study aims to evaluate CRB-701's efficacy and safety compared to current therapies, leveraging promising P…

YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada

YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada

YD Bio Limited announced a six-month pilot program in collaboration with Numia Health to evaluate a cross-border clinical workflow for physician-ordered, blood-based cancer testing for patients in British Columbia, Canada. The pilot aims to assess the scalability of integrating physician access, mobile blood collection, specimen logistics, and labo…

XFLT Proxy Vote: What Shareholders Need to Know About the Liquidity Plan and Discount Management Programs

XFLT Proxy Vote: What Shareholders Need to Know About the Liquidity Plan and Discount Management Programs

XAI Floating Rate & Alternative Income Trust (XFLT) announces a board-approved liquidity plan involving an initial and two contingent tender offers designed to support shareholder value through a Discount Management Program (DMP). Shareholders are urged to vote for the King Street Capital Management sub-advisory agreement enabling these offers. The…

Abundia Global Impact Group Announces Completion of the Process Design Package with Alterra Energy

Abundia Global Impact Group Announces Completion of the Process Design Package with Alterra Energy

Abundia Global Impact Group announced the completion of the Process Design Package (PDP) by Alterra Energy, marking an important engineering milestone for its planned 80,000 tons-per-annum waste plastics-to-fuels and chemicals facility in Baytown, Texas. This milestone allows Abundia to progress its Front-End Engineering Design phase by integrating…

authID and MajorKey Technologies Expand Partnership Through OEM Agreement, Embedding Verified and PrivacyKey Across MajorKey's Identity Security Portfolio

authID and MajorKey Technologies Expand Partnership Through OEM Agreement, Embedding Verified and PrivacyKey Across MajorKey's Identity Security Portfolio

authID announced an expanded OEM agreement with MajorKey Technologies to embed its Verified™, PrivacyKey™, and Proof™ biometric identity verification technologies directly into MajorKey’s identity security offerings. This allows MajorKey to deliver advanced privacy-preserving biometric verification across various high-risk identity workflows beyond…

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Firefly Neuroscience (NASDAQ: AIFF) and Next Health announced a strategic collaboration to develop a precision cognitive health platform combining Firefly's AI-powered FDA-cleared EEG/ERP brain biomarker system with personalized peptide protocols, such as Epitalon and Semax. This initiative aims to provide objective clinical measures to personalize…

Tesla Agrees to Buy Most Output from Arizona Solar-and-Storage Project

Tesla Agrees to Buy Most Output from Arizona Solar-and-Storage Project

Tesla has entered a long-term power purchase agreement to acquire 90% of the electricity output from Project Sterling, a large solar-plus-storage project in Arizona developed by ContourGlobal and backed by KKR & Co. The facility, scheduled to start operations in 2028, will feature 509 megawatts of peak solar capacity and 360 megawatts of four-hour …